DK1355646T3 - Muscariniske receptoragonister - Google Patents
Muscariniske receptoragonisterInfo
- Publication number
- DK1355646T3 DK1355646T3 DK01995477T DK01995477T DK1355646T3 DK 1355646 T3 DK1355646 T3 DK 1355646T3 DK 01995477 T DK01995477 T DK 01995477T DK 01995477 T DK01995477 T DK 01995477T DK 1355646 T3 DK1355646 T3 DK 1355646T3
- Authority
- DK
- Denmark
- Prior art keywords
- receptor agonists
- muscarinic receptor
- independently selected
- orand
- coch3
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/772,143 US6376675B2 (en) | 1999-01-22 | 2001-01-29 | Muscarinic receptor agonists |
PCT/US2001/047474 WO2002060444A1 (en) | 2001-01-29 | 2001-12-10 | Muscarinic receptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1355646T3 true DK1355646T3 (da) | 2009-08-17 |
Family
ID=25094053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01995477T DK1355646T3 (da) | 2001-01-29 | 2001-12-10 | Muscariniske receptoragonister |
Country Status (9)
Country | Link |
---|---|
US (2) | US6376675B2 (da) |
EP (1) | EP1355646B1 (da) |
JP (2) | JP2004520382A (da) |
AT (1) | ATE431143T1 (da) |
CA (1) | CA2434839A1 (da) |
DE (1) | DE60138732D1 (da) |
DK (1) | DK1355646T3 (da) |
ES (1) | ES2327104T3 (da) |
WO (1) | WO2002060444A1 (da) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8914114B2 (en) | 2000-05-23 | 2014-12-16 | The Feinstein Institute For Medical Research | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
US10912712B2 (en) | 2004-03-25 | 2021-02-09 | The Feinstein Institutes For Medical Research | Treatment of bleeding by non-invasive stimulation |
AU2005225458B2 (en) | 2004-03-25 | 2008-12-04 | The Feinstein Institutes For Medical Research | Neural tourniquet |
CN101124012B (zh) | 2004-12-27 | 2012-09-05 | 范因斯坦医学研究院 | 通过电刺激迷走神经治疗炎症性疾病的装置 |
US11207518B2 (en) | 2004-12-27 | 2021-12-28 | The Feinstein Institutes For Medical Research | Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway |
CN101374836A (zh) * | 2005-12-27 | 2009-02-25 | 托莱多大学 | 毒蕈碱激动剂及其使用方法 |
WO2008118326A1 (en) * | 2007-03-23 | 2008-10-02 | University Of Toledo | Muscarinic agonists and methods of use thereof |
WO2009029614A1 (en) | 2007-08-27 | 2009-03-05 | The Feinstein Institute For Medical Research | Devices and methods for inhibiting granulocyte activation by neural stimulation |
WO2009146030A1 (en) | 2008-03-31 | 2009-12-03 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation of t-cell activity |
US9662490B2 (en) | 2008-03-31 | 2017-05-30 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug |
EP2296471A4 (en) | 2008-05-15 | 2012-03-14 | Univ Toledo | MUSCARIC ACID AGONISTS AS COGNITIVE ENHANCERS |
WO2009152392A2 (en) * | 2008-06-11 | 2009-12-17 | University Of Toledo | Muscarinic agonists for neurological disorders and methods of making the same |
WO2010059617A2 (en) | 2008-11-18 | 2010-05-27 | Setpoint Medical Corporation | Devices and methods for optimizing electrode placement for anti-inflamatory stimulation |
US8996116B2 (en) | 2009-10-30 | 2015-03-31 | Setpoint Medical Corporation | Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction |
US8886339B2 (en) | 2009-06-09 | 2014-11-11 | Setpoint Medical Corporation | Nerve cuff with pocket for leadless stimulator |
US9211410B2 (en) | 2009-05-01 | 2015-12-15 | Setpoint Medical Corporation | Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
WO2014169145A1 (en) | 2013-04-10 | 2014-10-16 | Setpoint Medical Corporation | Closed-loop vagus nerve stimulation |
US9833621B2 (en) | 2011-09-23 | 2017-12-05 | Setpoint Medical Corporation | Modulation of sirtuins by vagus nerve stimulation |
AU2010336337B2 (en) | 2009-12-23 | 2016-02-04 | Setpoint Medical Corporation | Neural stimulation devices and systems for treatment of chronic inflammation |
WO2012149524A1 (en) | 2011-04-29 | 2012-11-01 | The University Of Toledo | Muscarinic agonists as enhancers of working memory and cognitive flexibility |
WO2012154865A2 (en) | 2011-05-09 | 2012-11-15 | Setpoint Medical Corporation | Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
US9572983B2 (en) | 2012-03-26 | 2017-02-21 | Setpoint Medical Corporation | Devices and methods for modulation of bone erosion |
US11311725B2 (en) | 2014-10-24 | 2022-04-26 | Setpoint Medical Corporation | Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation |
US11406833B2 (en) | 2015-02-03 | 2022-08-09 | Setpoint Medical Corporation | Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator |
US10596367B2 (en) | 2016-01-13 | 2020-03-24 | Setpoint Medical Corporation | Systems and methods for establishing a nerve block |
WO2017127756A1 (en) | 2016-01-20 | 2017-07-27 | Setpoint Medical Corporation | Control of vagal stimulation |
WO2017127758A1 (en) | 2016-01-20 | 2017-07-27 | Setpoint Medical Corporation | Implantable microstimulators and inductive charging systems |
US11471681B2 (en) | 2016-01-20 | 2022-10-18 | Setpoint Medical Corporation | Batteryless implantable microstimulators |
US10583304B2 (en) | 2016-01-25 | 2020-03-10 | Setpoint Medical Corporation | Implantable neurostimulator having power control and thermal regulation and methods of use |
EP3668402A4 (en) | 2017-08-14 | 2021-05-19 | Setpoint Medical Corporation | VAGUS NERVOUS STIMULATION PRE-SCREENING TEST |
US11660443B2 (en) | 2018-04-20 | 2023-05-30 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via electrical trigeminal nerve stimulation |
US11260229B2 (en) | 2018-09-25 | 2022-03-01 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
KR20230012585A (ko) | 2020-05-21 | 2023-01-26 | 더 파인스타인 인스티튜츠 포 메디칼 리서치 | 미주 신경 자극을 위한 시스템들 및 방법들 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5043345A (en) | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
US5376668A (en) * | 1990-08-21 | 1994-12-27 | Novo Nordisk A/S | Heterocyclic compounds |
DK198390D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
WO1993014089A1 (en) | 1992-01-13 | 1993-07-22 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
US5718912A (en) | 1996-10-28 | 1998-02-17 | Merck & Co., Inc. | Muscarine agonists |
US6096767A (en) | 1999-01-22 | 2000-08-01 | The University Of Toledo | Muscarinic receptor agonists |
-
2001
- 2001-01-29 US US09/772,143 patent/US6376675B2/en not_active Expired - Fee Related
- 2001-12-10 EP EP01995477A patent/EP1355646B1/en not_active Expired - Lifetime
- 2001-12-10 CA CA002434839A patent/CA2434839A1/en not_active Abandoned
- 2001-12-10 DE DE60138732T patent/DE60138732D1/de not_active Expired - Lifetime
- 2001-12-10 ES ES01995477T patent/ES2327104T3/es not_active Expired - Lifetime
- 2001-12-10 WO PCT/US2001/047474 patent/WO2002060444A1/en active Application Filing
- 2001-12-10 AT AT01995477T patent/ATE431143T1/de not_active IP Right Cessation
- 2001-12-10 JP JP2002560636A patent/JP2004520382A/ja not_active Ceased
- 2001-12-10 DK DK01995477T patent/DK1355646T3/da active
- 2001-12-20 US US10/034,229 patent/US6602891B2/en not_active Expired - Fee Related
-
2010
- 2010-03-02 JP JP2010045346A patent/JP2010159274A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ATE431143T1 (de) | 2009-05-15 |
US6602891B2 (en) | 2003-08-05 |
US20030032658A1 (en) | 2003-02-13 |
DE60138732D1 (de) | 2009-06-25 |
WO2002060444A1 (en) | 2002-08-08 |
US20010036953A1 (en) | 2001-11-01 |
CA2434839A1 (en) | 2002-08-08 |
EP1355646A1 (en) | 2003-10-29 |
JP2004520382A (ja) | 2004-07-08 |
EP1355646B1 (en) | 2009-05-13 |
EP1355646A4 (en) | 2004-06-16 |
US6376675B2 (en) | 2002-04-23 |
JP2010159274A (ja) | 2010-07-22 |
ES2327104T3 (es) | 2009-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1355646T3 (da) | Muscariniske receptoragonister | |
EP1423370A4 (en) | COMPOUNDS BINDING TO THE NUCLEAR FXR-NR1H4 RECEPTOR | |
EA200400794A1 (ru) | Фармацевтическая композиция антагониста рецептора тахикинина в форме наночастиц | |
CA2536870A1 (en) | Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists | |
EP1882686A3 (en) | Pyrrolidine and piperidine derivates as nk1 antagonists | |
MY119118A (en) | Thiophenopyrimidines | |
EA200101223A1 (ru) | Новые соединения, их применение и получение | |
WO2004089366A8 (en) | Bicyclic compounds as nr2b receptor antagonists | |
FI905839A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten trisyklisten, typpipitoisten yhdisteiden valmistamiseksi | |
LU91761I2 (fr) | Vernakalant et ses dérivés pharmaceutiquement acceptables et en particulier son sel d'hydrochlorure (BRINAVESS®) | |
GEP20084519B (en) | 3-(4-heteroarylcyclo-hexylamino) cyclopenta-necarboxamides as modulators of chemokine receptors | |
MXPA00006605A (es) | Compuestos de carbonil-indol biciclicos como agentes antiinflamatorios/analgesicos. | |
PL361361A1 (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists | |
EA200501593A1 (ru) | Азабициклические производные в качестве антагонистов мускаринового рецептора | |
BR0006371A (pt) | Compostos de 1,4-dihidropiridina substituìdos com heteroarilas de 5 membros como antagonistas de bradicinina | |
EP1253139A3 (en) | Multioligoanilinated fullerenes | |
ATE121732T1 (de) | Maleimidverbindungen und diese enthaltende fungizide. | |
DE60110233D1 (de) | Neue n-(2-phenyl-3-aminopropyl)naphtamide | |
GR3035379T3 (en) | Tetrazolyl-substituted quinuclidines as substance P antagonists | |
SE9901884D0 (sv) | Novel compounds their use and preparation | |
ES2150739T3 (es) | Compuestos triciclicos de piperidinilamino como antagonistas de sustancia p. |